Studies have demonstrated that upon stimulation with LPS, the activation of VIPR1 can effectively suppress inflammatory responses, inhibit the release of inflammatory mediators, diminish cellular and DNA damage resulting from inflammation, and exert a restraining effect on tumor development and progression (Delgado and Ganea, 2013). This evidence concerns the gene VIPR1 and neoplasm.